FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

37833911000001103: Lamivudine 300mg / Tenofovir disoproxil 245mg tablets (Cipla EU Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 27-Nov 2019. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
472691000001119 Lamivudine 300mg / Tenofovir disoproxil 245mg tablets (Cipla EU Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
472701000001119 Lamivudine 300mg / Tenofovir disoproxil 245mg tablets (Cipla EU Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Lamivudine 300mg / Tenofovir disoproxil 245mg tablets (Cipla EU Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Lamivudine 300mg / Tenofovir disoproxil 245mg tablets (Cipla EU Ltd) Is a Lamivudine 300mg / Tenofovir disoproxil 245mg tablets true Inferred relationship Existential restriction modifier
Lamivudine 300mg / Tenofovir disoproxil 245mg tablets (Cipla EU Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Lamivudine 300mg / Tenofovir disoproxil 245mg tablets (Cipla EU Ltd) VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Lamivudine 300mg / Tenofovir disoproxil 245mg tablets (Cipla EU Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Lamivudine 300mg / Tenofovir disoproxil 245mg tablets (Cipla EU Ltd) Has specific active ingredient Tenofovir disoproxil fumarate true Inferred relationship Existential restriction modifier
Lamivudine 300mg / Tenofovir disoproxil 245mg tablets (Cipla EU Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Lamivudine 300mg / Tenofovir disoproxil 245mg tablets (Cipla EU Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Tenofovir disoproxil true Inferred relationship Existential restriction modifier
Lamivudine 300mg / Tenofovir disoproxil 245mg tablets (Cipla EU Ltd) Has specific active ingredient Lamivudine true Inferred relationship Existential restriction modifier
Lamivudine 300mg / Tenofovir disoproxil 245mg tablets (Cipla EU Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Lamivudine 300mg / Tenofovir disoproxil 245mg tablets (Cipla EU Ltd) VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Lamivudine 300mg / Tenofovir disoproxil 245mg tablets (Cipla EU Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Lamivudine 300mg / Tenofovir disoproxil 245mg tablets (Cipla EU Ltd) 30 tablet Has AMP True Lamivudine 300mg / Tenofovir disoproxil 245mg tablets (Cipla EU Ltd) Inferred relationship Existential restriction modifier
Lamivudine 300mg / Tenofovir disoproxil 245mg tablets (Cipla EU Ltd) 90 tablet Has AMP True Lamivudine 300mg / Tenofovir disoproxil 245mg tablets (Cipla EU Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start